Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Does Rh immune globulin suppress HLA sensitization in pregnancy?

Kaufman RM, Schlumpf KS, Wright DJ, Triulzi DJ; NHLBI Retrovirus Epidemiology Donor Study-II.

Transfusion. 2013 Sep;53(9):2069-77. doi: 10.1111/trf.12049. Epub 2012 Dec 17.

2.

Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.

Aitken SL, Tichy EM.

Am J Health Syst Pharm. 2015 Feb 15;72(4):267-76. doi: 10.2146/ajhp140288. Review.

PMID:
25631833
3.

Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration?

Ma KK, Rodriguez MI, Cheng YW, Norton ME, Caughey AB.

J Matern Fetal Neonatal Med. 2016;29(11):1866-70. doi: 10.3109/14767058.2015.1066773. Epub 2015 Aug 13.

PMID:
26169705
4.

One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.

Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE.

Transfusion. 2008 Aug;48(8):1721-9. doi: 10.1111/j.1537-2995.2008.01742.x. Epub 2008 May 23.

PMID:
18507749
5.

Costs and benefits of non-invasive fetal RhD determination.

Teitelbaum L, Metcalfe A, Clarke G, Parboosingh JS, Wilson RD, Johnson JM.

Ultrasound Obstet Gynecol. 2015 Jan;45(1):84-8. doi: 10.1002/uog.14723.

6.

Utilization of Rh prophylaxis.

Berger GS, Keith L.

Clin Obstet Gynecol. 1982 Jun;25(2):267-75.

PMID:
6179676
7.

Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.

Rushin J, Rumsey DH, Ewing CA, Sandler SG.

Transfusion. 2000 May;40(5):551-4.

PMID:
10827257
8.

Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis.

Szkotak AJ, Lunty B, Nahirniak S, Clarke G.

Vox Sang. 2016 Jan;110(1):51-9. doi: 10.1111/vox.12302. Epub 2015 May 29.

PMID:
26031621
9.

Pathology Consultation on Patients With a Large Rh Immune Globulin Dose Requirement.

Welsh KJ, Bai Y; Education Committee of the Academy of Clinical Laboratory Physicians and Scientists.

Am J Clin Pathol. 2016 Jun;145(6):744-51. doi: 10.1093/ajcp/aqw051. Epub 2016 Jun 6. Review.

PMID:
27267375
10.

Prevention of Rh sensitization in the context of trauma: two case reports.

Werch JB.

J Clin Apher. 2010;25(2):70-3. doi: 10.1002/jca.20225.

PMID:
20027640
11.

High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.

Verduin EP, Schonewille H, Brand A, Haasnoot GW, Claas FH, Lindenburg IT, Lopriore E, Oepkes D, Roelen DL, Doxiadis II.

Transfusion. 2013 May;53(5):939-47. doi: 10.1111/j.1537-2995.2012.03862.x. Epub 2012 Aug 23.

PMID:
22924899
12.

Accurate quantitation of D+ fetomaternal hemorrhage by flow cytometry using a novel reagent to eliminate granulocytes from analysis.

Kumpel B, Hazell M, Guest A, Dixey J, Mushens R, Bishop D, Wreford-Bush T, Lee E.

Transfusion. 2014 May;54(5):1305-16. doi: 10.1111/trf.12484. Epub 2013 Nov 17.

PMID:
24236535
13.

Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.

Mackenzie IZ, Roseman F, Findlay J, Thompson K, McPherson K.

Eur J Obstet Gynecol Reprod Biol. 2008 Jul;139(1):38-42. doi: 10.1016/j.ejogrb.2007.12.002. Epub 2008 Feb 20.

PMID:
18243487
15.

Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?

Koby L, Grunbaum A, Benjamin A, Koby R, Abenhaim HA.

J Obstet Gynaecol Can. 2012 May;34(5):429-435. doi: 10.1016/S1701-2163(16)35239-2.

PMID:
22555135
16.

Prevention of Rh alloimmunization.

Fung Kee Fung K, Eason E, Crane J, Armson A, De La Ronde S, Farine D, Keenan-Lindsay L, Leduc L, Reid GJ, Aerde JV, Wilson RD, Davies G, D├ęsilets VA, Summers A, Wyatt P, Young DC; Maternal-Fetal Medicine Committee, Genetics Committee.

J Obstet Gynaecol Can. 2003 Sep;25(9):765-73.

PMID:
12970812
17.

Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.

McBain RD, Crowther CA, Middleton P.

Cochrane Database Syst Rev. 2015 Sep 3;(9):CD000020. doi: 10.1002/14651858.CD000020.pub3. Review.

PMID:
26334436
18.

Intravenous Rh immune globulin prevents alloimmunization in D- granulocyte recipients but obscures the detection of an allo-anti-K.

Stroncek DF, Procter JL, Moses L, Bolan C, Pomper GJ, Conroy-Cantilena C, Malech HL, Klein HG, Leitman SF.

Immunohematology. 2001;17(2):37-41.

PMID:
15373589
20.

Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin.

Branch DR, Scofield TL, Moulds JJ, Swanson JL.

Transfusion. 2011 Apr;51(4):816-9. doi: 10.1111/j.1537-2995.2010.02905.x. Epub 2010 Oct 7.

PMID:
20946183

Supplemental Content

Support Center